Tuesday, June 6, 2023
Home 2023 March

Monthly Archives: March 2023

Incubator

Smart for Life (SMFL) Reports Revenue Increases 96.9% to $17.8 Million...

Editor / Curator -
Marijuana Stock Review

Adding Vext Science (VEXTF) $0.17 to the Watch List.

Editor / Curator -
Incubator

Report: Think Equity Updates Society Pass (SOPA). $6.00 Price Target.

Editor / Curator -
Alternative Energy

IA Initiates Analyst Coverage of Principal Solar (Press Release).

Editor / Curator -
All News

Selling ARK (ARKK) & Buying AXS Short Innovation (SARK) ETF.

Editor / Curator -
2022 Watch List

We’re Bearish, but we’re up 257% in Provention Bio (PRVB) Today.

Editor / Curator -
All News

Interview: Rokas Sidlauskas, Marketing Director of Society Pass (SOPA)

Editor / Curator -
Internet Stock Review, Biotech Stock Review, Roland Rick Perry
2023 Watch List

Unicycive Therapeutics (UNCY) $2.73 Tacks on Another 30%. We’re now up...

Editor / Curator -
Psychedelic News

Prince Harry Says Psychedelics Are a “Fundamental Part” of His Life...

Editor / Curator -
All News

Meet Dennis Nguyen CEO of Start-Up Investor, the Society Pass (Symbol:...

Editor / Curator -
12Page 1 of 2

Latest article

Asia-Pacific: A Region of Stability Amidst Economic Uncertainty

2022 Watch List Editor / Curator -
Contrary to the Western markets, there is a growing consensus that the Asia Pacific is emerging as a relatively safe harbour in...

Hepion (HEPA) Back in the Spotlight, Gains 230% in May.

2020 Watch List Editor / Curator -
Hepion (HEPA) Phase 2 ‘ALTITUDE-NASH’ Trial Achieves Primary and Secondary Endpoints, Including Improvement in Liver Function and...

Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating...

2023 Watch List Editor / Curator -
A pre-clinical observational study published in Drug Development & Delivery found that more than 80% of patients experienced relief within minutes of...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.